Lamotrigine (Lamictal) Side Effects
Lamotrigine is generally well-tolerated, but serious skin reactions—including Stevens-Johnson syndrome—represent the most critical risk, particularly during the initial titration phase, while common side effects include dizziness, headache, nausea, and diplopia. 1
Serious and Life-Threatening Side Effects
Skin Reactions (Most Critical)
- Serious rash requiring hospitalization and discontinuation occurs in approximately 0.3% of adults, with Stevens-Johnson syndrome representing the most severe manifestation 1, 2
- The overall incidence of allergic skin reactions is approximately 5.1%, with 3.9% requiring drug withdrawal 2
- Risk factors for severe rash include:
- Timing: 90% of allergic skin reactions appear during the initiation/titration phase 2
- The rash can progress to life-threatening conditions including Stevens-Johnson syndrome and toxic epidermal necrolysis 4, 1
Cardiac Effects
- Lamotrigine causes a modest (3.1%) increase in PR interval (atrioventricular conduction time), but this is not associated with clinically pathological ECG abnormalities 5
- The FDA issued warnings about potential cardiac rhythm and conduction abnormalities, particularly in patients with pre-existing heart disease 1, 5
- However, real-world studies show no increased deaths from cardiac causes or unambiguous cardiac complications, even in vulnerable populations 6
- Each 1-μg/mL increase in serum concentration is associated with a 2.3% increase in PR interval 5
Aseptic Meningitis
- Can occur as a serious adverse reaction requiring immediate discontinuation 1
Common Side Effects (>5% incidence)
Neurological
- Dizziness (14% vs. 6% placebo) 1
- Tremor and intention tremor (6% vs. 1% placebo) 1
- Headache 1
- Somnolence (5% vs. 3% placebo) 1
- Cerebellar coordination and balance disorders (3%) 1
- Nystagmus (2%) 1
Gastrointestinal
- Nausea (9% vs. 4% placebo) 1
- Diarrhea (6% vs. 4% placebo) 1
- Vomiting (5% vs. 2% placebo) 1
- Constipation (2%) 1
Visual
Other Common Effects
Psychiatric Side Effects
- Affective switches, acute psychotic episodes, and hallucinations have been reported in patients using lamotrigine for both epilepsy and mood disorders 7
- Depression may emerge or worsen; patients should be counseled about this risk before starting therapy 1
- Suicidal thoughts or behavior can occur, as with all antiepileptic drugs 1
Dose-Related Considerations
- Many adverse reactions are more common during the titration phase than the maintenance phase 1
- Adverse reactions developing during titration that commonly persist include somnolence and dizziness 1
- In monotherapy studies, doses >200 mg showed similar adverse effect rates to lower doses (4.8% vs. 7.7% for 100-200 mg) 3
- Long-term use (>6 months) is very well tolerated, even at high maintenance doses, with only 2 of 54 patients discontinuing due to adverse effects after 6 months 3
Drug Interactions Affecting Side Effects
- Valproic acid significantly increases lamotrigine levels and rash risk, requiring dose reduction 1, 2
- Enzyme-inducing antiepileptics (carbamazepine, phenytoin, phenobarbital) decrease lamotrigine levels 8, 1
- Oral contraceptives can decrease lamotrigine effectiveness and cause breakthrough bleeding 1
Special Populations
Pregnancy and Breastfeeding
- Lamotrigine clearance increases during pregnancy, requiring dose adjustments 9
- The drug passes into breast milk and may cause breathing problems, sleepiness, or poor sucking in infants 1
Elderly
- Patients prone to dehydration may experience more severe gastrointestinal effects 8
Clinical Monitoring Recommendations
- Patients with a history of allergies require closer monitoring during initiation 3
- Most adverse effects occur early; if patients tolerate lamotrigine for 6 months, long-term continuation is generally well-tolerated 3
- Weight should be monitored, though weight changes are not commonly reported with lamotrigine (unlike some other mood stabilizers) 8